These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human umbilical cord blood biology, transplantation and plasticity. Goldstein G, Toren A, Nagler A. Curr Med Chem; 2006; 13(11):1249-59. PubMed ID: 16712468 [Abstract] [Full Text] [Related]
3. [Umbilical cord blood as a source of stem cells]. Bojanić I, Golubić Cepulić B. Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834 [Abstract] [Full Text] [Related]
8. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA, Willemze R, Fibbe WE. Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548 [Abstract] [Full Text] [Related]
15. UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities. Dumont-Lagacé M, Feghaly A, Meunier MC, Finney M, Van't Hof W, Masson Frenet E, Sauvageau G, Cohen S. Transplant Cell Ther; 2022 Jul; 28(7):410.e1-410.e5. PubMed ID: 35311667 [Abstract] [Full Text] [Related]
16. Non-fucosylated CB CD34+ cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantation. Robinson SN, Thomas MW, Simmons PJ, Lu J, Yang H, Javni JA, Shpall EJ, Zweidler-Mckay PA. Cytotherapy; 2017 Feb; 19(2):285-292. PubMed ID: 27919572 [Abstract] [Full Text] [Related]